https://doi.org/10.4081/cdr.13.12743
A case report of co-infection with two atypical pathogens: a particular case report
Submitted: 24 June 2024
Accepted: 14 November 2024
Published: 16 January 2025
Accepted: 14 November 2024
Abstract Views: 480
PDF: 29
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
This case report describes a young asthmatic patient who contracted a dual infection with Chlamydia pneumoniae and Mycoplasma pneumoniae. The co-infection exacerbated the asthmatic symptoms, leading to significant complications. A literature review highlights how such atypical infections can aggravate respiratory conditions in patients with pre-existing asthma. Clinical patient management, including antibiotic therapy and respiratory support, led to a progressive resolution of the clinical picture. This case underscores the importance of considering atypical infections in the differential diagnosis of asthmatic patients with acute symptom worsening.
Orders M. Antibacterial drugs for community-acquired pneumonia. Med Lett Drugs Ther 2021;63:10-5.
Blasi F, Tarsia P, Aliberti S, et al. Chlamydia pneumoniae and Mycoplasma pneumoniae. Semin Respir Crit Care Med 2005;26:617-24.
DOI: https://doi.org/10.1055/s-2005-925525
De Francesco MA, Poiesi C, Gargiulo F, et al. Co-infection of Chlamydia pneumoniae and Mycoplasma pneumoniae with SARS-CoV-2 is associated with more severe features. J Infect 2021;82:e4-7.
DOI: https://doi.org/10.1016/j.jinf.2021.01.009
Cunha BA. The atypical pneumonias: clinical diagnosis and importance. Clin Microbiol Infect 2006;12:12-24.
DOI: https://doi.org/10.1111/j.1469-0691.2006.01393.x
Esposito S, Blasi F, Arosio C, et al. Importance of acute Mycoplasma pneumoniae and Chlamydia pneumoniae infections in children with wheezing. Eur Respir J 2000;16:1142-6.
DOI: https://doi.org/10.1034/j.1399-3003.2000.16f21.x
Garin N, Marti C, Skali Lami A, Prendki V. Atypical pathogens in adult community-acquired pneumonia and implications for empiric antibiotic treatment: a narrative review. Microorganisms 2022;10:2326.
DOI: https://doi.org/10.3390/microorganisms10122326
Iramain R, De Jesús R, Spitters C, et al. Chlamydia pneumoniae and Mycoplasma pneumoniae: are they related to severe asthma in childhood? J Asthma 2016;53:618-21.
DOI: https://doi.org/10.3109/02770903.2015.1116085
Mandell LA. Community-acquired pneumonia: an overview. Postgrad Med 2015;127:607-15.
DOI: https://doi.org/10.1080/00325481.2015.1074030
Meyer Sauteur PM, Beeton ML, European Society of Clinical Microbiology and Infectious Diseases (ESCMID) et al. Mycoplasma pneumoniae: delayed re-emergence after COVID-19 pandemic restrictions. Lancet Microbe 2024;5:e100-1.
Meyer Sauteur PM, Beeton ML, Uldum SA, et al. Mycoplasma pneumoniae detections before and during the COVID-19 pandemic: results of a global survey, 2017 to 2021. Euro Surveill 2022;27:2100746.
DOI: https://doi.org/10.2807/1560-7917.ES.2022.27.19.2100746
Oliva A, Siccardi G, Migliarini A, et al. Co-infection of SARS-CoV-2 with Chlamydia or Mycoplasma pneumoniae: a case series and review of the literature. Infection 2020;48:871-7.
DOI: https://doi.org/10.1007/s15010-020-01483-8
Pittet LF, Bertelli C, Scherz V, et al. Chlamydia pneumoniae and Mycoplasma pneumoniae in children with cystic fibrosis: impact on bacterial respiratory microbiota diversity. Pathog Dis 2021;79:ftaa074.
DOI: https://doi.org/10.1093/femspd/ftaa074
Principi N, Esposito S. Mycoplasma pneumoniae and Chlamydia pneumoniae cause lower respiratory tract disease in paediatric patients. Curr Opin Infect Dis 2002;15:295-300.
DOI: https://doi.org/10.1097/00001432-200206000-00013
Sidal M, Kilic A, Unuvar E, et al. Frequency of Chlamydia pneumoniae and Mycoplasma pneumoniae infections in children. J Trop Pediatr 2007;53:225-31.
DOI: https://doi.org/10.1093/tropej/fmm003
Tsai MK, Lai CH, Tsai C, Chen GL. Mycoplasma pneumoniae and Chlamydia pneumoniae coinfection with acute respiratory distress syndrome: a case report. Diagnostics (Basel) 2021;12:48.
DOI: https://doi.org/10.3390/diagnostics12010048
How to Cite
Scaramozzino, M. U., Nassisi, V., Loddo, F., & Sapone, G. (2025). A case report of co-infection with two atypical pathogens: a particular case report. Chest Disease Reports, 13(1). https://doi.org/10.4081/cdr.13.12743
Copyright (c) 2025 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
